Mozzwise tracks 5 mosquito-borne diseases in Haiti based on WHO, CDC, and ECDC surveillance. Each entry below cross-links to a full Mozzwise disease briefing.
Dengue Fever is recorded in Haiti with moderate severity according to current surveillance. Travelers to endemic areas, young children, pregnant women, and people with prior dengue infection. A second infection with a different serotype carries a significantly higher risk of severe disease. Reported globally in: Tropical and subtropical regions worldwide — Southeast Asia, Latin America, Sub-Saharan Africa, Pacific Islands.
Chikungunya is tracked as present in Haiti based on historical surveillance, though active transmission is not currently flagged. Elderly travelers, newborns, and people with chronic conditions like diabetes or heart disease. The debilitating joint pain can persist for months or years, significantly affecting quality of life. Reported globally in: Africa, Asia, Indian subcontinent, Americas. Expanding into southern Europe (Italy, France, Spain).
Lymphatic Filariasis is tracked as present in Haiti based on historical surveillance, though active transmission is not currently flagged. Long-term residents and expats in endemic tropical areas. Very rare in short-term tourists. The infection requires sustained, repeated exposure over months — a two-week holiday is extremely unlikely to result in infection. Reported globally in: Tropical Africa, South Asia, Southeast Asia, Pacific Islands. Approximately 47 endemic countries.
Malaria is tracked as present in Haiti based on historical surveillance, though active transmission is not currently flagged. Young children under 5, pregnant women, and travelers without immunity are most vulnerable. Around 600,000 people die from malaria each year. The right precautions and prophylaxis make all the difference. Reported globally in: Sub-Saharan Africa (90% of cases), South and Southeast Asia, Central and South America, Middle East.
Zika Virus is tracked as present in Haiti based on historical surveillance, though active transmission is not currently flagged. Pregnant women and those planning pregnancy are the primary concern. The virus can cause devastating birth defects including microcephaly. Most adults recover without issues within a week. Reported globally in: Tropical Americas, Southeast Asia, Pacific Islands. Ongoing low-level transmission since the 2015-2016 epidemic.